Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow-to-Debt Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow-to-debt ratio. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow-to-Debt Ratio of 0.25x as of December 2025, meaning its operating cash flow of CN¥837.18 Million could theoretically repay 0% of its total liabilities (CN¥3.33 Billion) in one year. Check how high is Anhui Huaren Health Pharmaceutical Co. L's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Cash flow-to-debt ratio of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. Historical debt coverage capacity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Check how aggressively does Anhui Huaren Health Pharmaceutical Co. L reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow-to-Debt Ratio by Year (2021–2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For the full cash flow conversion analysis, see 301408 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥837.18 Million | CN¥3.33 Billion | ▲ +21.9% |
| 2024 | 0.21x | CN¥571.76 Million | CN¥2.77 Billion | ▲ +314.4% |
| 2023 | 0.05x | CN¥131.37 Million | CN¥2.64 Billion | ▼ -53.3% |
| 2022 | 0.11x | CN¥173.84 Million | CN¥1.63 Billion | ▼ -10.1% |
| 2021 | 0.12x | CN¥140.82 Million | CN¥1.19 Billion | — |